Q15078 (CD5R1_HUMAN) Homo sapiens (Human)

Cyclin-dependent kinase 5 activator 1 UniProtKBInterProSTRINGInteractive Modelling

307 aa; Sequence (Fasta) ; 14 identical sequences

Available Structures

11 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structural mechanism for the inhibition of CD5-p25 from the roscovitine, aloisine and indirubin. Heteromer
Q00535;
145-294
100RRC;
Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin. Heteromer
Q00535;
145-294
100ALH;
Crystal Structure of Cdk5:p25 in complex with an ATP analogue Heteromer
Q00535;
145-293
100
The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1 Heteromer
Q00535;
146-293
10065L; 10×EDO;PEG;CL;GOL;
Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin. Heteromer
Q00535;
147-294
100IXM;
The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 13 Heteromer
Q00535;
146-293
10063I;PGE;EDO;
The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 7 Heteromer
Q00535;
146-293
10064V;
The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24 Heteromer
Q00535;
146-293
10061U;GOL; 17×EDO; 19×CL;
Structure and regulation of the CDK5-p25(nck5a) complex Heteromer
Q00535;
147-293
100
Structure of CDK5R1-bound FEM1Cmonomer298-307
100.0SO4;
Structure of CDK5R1 bound FEM1Bmonomer298-307
100.0SO4;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1ung.1.Bmonomer0.86145-293
100.00